Shoulder Innovations, Inc.(SI)

Medical - Specialties · Grand Rapids, MI

$19.01+0.26 (+1.39%)

Delayed quote: Oct 2, 2026, 4:00 PM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-04T08:13:57.053Z.

Stored calculation inputs

Calculation as of: 2026-10-04T08:13:57.053Z.

Quote observation: 2026-10-02T20:00:02.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -31,065,000
Quote market capitalization: 394,233,676
Total debt · period ending 2026-06-30: 14,850,000
Cash · period ending 2026-06-30: 24,460,000

FMP input reference: 57b60877cfd9fa538daf0f8b567712afefe99729f4ad10ceac90ec610a13b4bd

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

SI EBITDA Yield Metrics

EBITDA YIELD

N/A

SI Competitors' EBITDA Yield

Shoulder Innovations, Inc.

Current

Market Cap

$394.23M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NRC

NRC Health

vs SI

Market Cap

$458.62M

EBITDA Yield

4.28%

TTM Avg

6.57%

3Y Avg

7.36%

5Y Avg

6.54%

NEO

NeoGenomics, Inc.

vs SI

Market Cap

$474.59M

EBITDA Yield

N/A

TTM Avg

1.44%

3Y Avg

5.28%

5Y Avg

7.05%

PDSB

PDS Biotechnology Corporation

vs SI

Market Cap

$41.86M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TDOC

Teladoc Health, Inc.

vs SI

Market Cap

$1.00B

EBITDA Yield

8.03%

TTM Avg

4.49%

3Y Avg

2.38%

5Y Avg

2.38%

NTLA

Intellia Therapeutics, Inc.

vs SI

Market Cap

$1.71B

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

XRAY

DENTSPLY SIRONA Inc.

vs SI

Market Cap

$1.74B

EBITDA Yield

22.42%

TTM Avg

15.00%

3Y Avg

6.67%

5Y Avg

7.28%

FTRE

Fortrea Holdings Inc.

vs SI

Market Cap

$1.90B

EBITDA Yield

3.13%

TTM Avg

2.90%

3Y Avg

2.57%

5Y Avg

2.99%

INSP

Inspire Medical Systems, Inc.

vs SI

Market Cap

$2.02B

EBITDA Yield

3.71%

TTM Avg

3.63%

3Y Avg

2.44%

5Y Avg

2.44%

RXRX

Recursion Pharmaceuticals, Inc.

vs SI

Market Cap

$2.16B

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Shoulder Innovations, Inc. (SI)	$394.23M	N/A	N/A	N/A	N/A
NRC Health (NRC)vs ›	$458.62M	4.28%	6.57%	7.36%	6.54%
NeoGenomics, Inc. (NEO)vs ›	$474.59M	N/A	1.44%	5.28%	7.05%
PDS Biotechnology Corporation (PDSB)vs ›	$41.86M	N/A	N/A	N/A	N/A
Teladoc Health, Inc. (TDOC)vs ›	$1.00B	8.03%	4.49%	2.38%	2.38%
Intellia Therapeutics, Inc. (NTLA)vs ›	$1.71B	N/A	N/A	N/A	N/A
DENTSPLY SIRONA Inc. (XRAY)vs ›	$1.74B	22.42%	15.00%	6.67%	7.28%
Fortrea Holdings Inc. (FTRE)vs ›	$1.90B	3.13%	2.90%	2.57%	2.99%
Inspire Medical Systems, Inc. (INSP)vs ›	$2.02B	3.71%	3.63%	2.44%	2.44%
Recursion Pharmaceuticals, Inc. (RXRX)vs ›	$2.16B	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

SI EBITDA Yield Metrics

SI Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics